Sign in

NCT06134752Active, not recruiting

Electroporation for Treatment of Atrial Fibrillation

Electroporation for Treatment of Persistent and Longstanding Persistent Atrial Fibrillation

Source: ClinicalTrials.gov · Last updated 11 Feb 2026

Brief summary (registry, in English)

Comparison of pulmonary vein and left atrial posterior wall isolation durability and clinical outcome between radiofrequency and pulse field ablation in patients with persistent and longstanding persistent atrial fibrillation.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
8 Nov 2023
Start date
5 Dec 2023
Primary completion date
15 Feb 2027
Lead sponsor
University Medical Centre Ljubljana
NCT number
NCT06134752

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 5 Dec 2023 to the primary completion date, 15 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • history of previous catheter ablation, history of previous heart surgery, life expectancy less than one year, any lifethreatening severe acute condition, acute deep venous thrombosis, presence of intracardiac masses or thrombi.

Who the study is looking for

  • atrial fibrillation recorded with 12-lead ECG, holter ECG or implantable device on two occasions at least one week apart

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cardiovascular Surgery Department, University Medical Centre Ljubljana
Coordinator of this site? Confirm its status
LjubljanaSloveniaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.